99274-3 |
Flubromazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Flubromazepam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99274-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Flubromazepam Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99275-0 |
Phenazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Phenazepam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99275-0 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Phenazepam Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Phenazapam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99276-8 |
3-Hydroxyphenazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
3-Hydroxyphenazepam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99276-8 |
|
Confirm |
|
|
Both |
|
|
|
0 |
3-OH-phenazepam Ur Cfm-mCnc |
|
|
|
N |
|
3-OH-phenazepam; 3-Oxyfenazepam; Benzodiazepine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; III; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99277-6 |
Pyrazolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Pyrazolam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99277-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Pyrazolam Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Pirazolam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99278-4 |
Flubromazolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Flubromazolam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99278-4 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Flubromazolam Ur Cfm-mCnc |
|
|
|
N |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; flubromazolam; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99279-2 |
Alpha-hydroxy flubromazolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Alpha-hydroxy flubromazolam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99279-2 |
|
Confirm |
|
|
Both |
|
|
|
0 |
A-OH flubromazolam Ur Cfm-mCnc |
|
|
|
N |
|
Addiction; Alfa; A-OH flubromazolam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; flubromazolam; GCMS; Hydrox; Illicit; LC/MS/MS; Level; Mass concentration; OH; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
9928-3 |
Q wave depth.lead I |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead I |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9928-3 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-I |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-I; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99280-0 |
Cefiderocol |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Cefiderocol [Susceptibility] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
99280-0 |
|
|
|
|
Both |
|
|
|
0 |
Cefiderocol Susc Islt |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Fetcroja; Fetroja; Islt; Isol; Point in time; Random; Siderophore cephalosporin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99281-8 |
Lefamulin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Lefamulin [Susceptibility] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
99281-8 |
|
|
|
|
Both |
|
|
|
0 |
Lefamulin Susc Islt |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99282-6 |
FDA-initiated compliance action drug registration and listing inactivation - animal drug |
- |
^FDA product label |
- |
Nar |
|
|
ACTIVE |
FDA product label FDA-initiated compliance action drug registration and listing inactivation - animal drug |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.REF |
|
99282-6 |
|
|
|
|
Both |
|
|
|
0 |
FDA animal drug+list inactivation |
|
|
|
N |
|
DOCUMENT.REF; Drugs; FDA compl action drug and list inact; FDA drug+list inactive - animal drug; FDA label; Narrative; Report |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99283-4 |
Tegner activity scale panel |
- |
^Patient |
Pt |
- |
Tegner |
|
ACTIVE |
Tegner Activity Scale panel [Tegner] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.GNHLTH |
|
99283-4 |
|
Tegner |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Activ; Actvty; Movements; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; TAS panel |
2.72 |
2.72 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
99284-2 |
Activity level before injury |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Activity level before injury |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
99284-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Activ; Actvty; Finding; Findings; Levels; Levl; LV; LVL; Movements; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH; Ulcer |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99285-9 |
Current activity level |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Current activity level |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
99285-9 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Activ; Actvty; Finding; Findings; Levels; Levl; LV; LVL; Movements; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99286-7 |
Provision of current reconciled medication list to subsequent provider at transfer |
Find |
^Patient |
RptPeriod |
Ord |
CMS Assessment |
|
ACTIVE |
Provision of current reconciled medication list to subsequent provider at transfer during assessment period [CMS Assessment] |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
99286-7 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Reconciled med list; Report period; Screen; Survey |
2.77 |
2.72 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; |
0 |
99287-5 |
Checklist of nonverbal pain indicators panel |
- |
^Patient |
Pt |
- |
CNPI |
|
ACTIVE |
Checklist of nonverbal pain indicators panel [CNPI] |
|
ADD |
DefinitionDescription |
|
|
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
PANEL.SURVEY.CNPI |
|
99287-5 |
|
CNPI |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
CNPI panel; Nonverb pain ind; Pan; Panl; Pnl; Point in time; Random; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
Panel |
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
|
|
0 |
99288-3 |
Checklist of nonverbal pain indicators with movement panel |
- |
^Patient |
Pt |
- |
CNPI |
|
ACTIVE |
Checklist of nonverbal pain indicators with movement panel [CNPI] |
|
ADD |
DefinitionDescription |
|
|
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
PANEL.SURVEY.CNPI |
|
99288-3 |
|
CNPI |
|
|
Subset |
|
|
|
0 |
|
|
|
|
N |
|
CNPI movement panel; Nonverb pain ind; Pan; Panl; Pnl; Point in time; Random; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
Organizer |
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
|
|
0 |
99289-1 |
Nonverbal vocal complaints during movement |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Nonverbal vocal complaints during movement |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99289-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Nonverb complaint during movement; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9929-1 |
Q wave depth.lead II |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead II |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9929-1 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-II |
|
|
|
Y |
|
2; Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-II; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99290-9 |
Facial grimaces or winces during movement |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Facial grimaces or winces during movement |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99290-9 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Grimaces/winces during movement; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99291-7 |
Bracing during movement |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Bracing during movement |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99291-7 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99292-5 |
Rubbing during movement |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Rubbing during movement |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99292-5 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99293-3 |
Restlessness during movement |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Restlessness during movement |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99293-3 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99294-1 |
Verbal complaints during movement |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Verbal complaints during movement |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99294-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99295-8 |
With movement score |
Score |
^Patient |
Pt |
Qn |
CNPI |
|
ACTIVE |
With movement score [CNPI] |
|
ADD |
DefinitionDescription |
|
|
score |
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
SURVEY.CNPI |
|
99295-8 |
|
CNPI |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
{score} |
|
|
|
0 |
99296-6 |
Checklist of nonverbal pain indicators at rest panel |
- |
^Patient |
Pt |
- |
CNPI |
|
ACTIVE |
Checklist of nonverbal pain indicators at rest panel [CNPI] |
|
ADD |
DefinitionDescription |
|
|
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
PANEL.SURVEY.CNPI |
|
99296-6 |
|
CNPI |
|
|
Subset |
|
|
|
0 |
|
|
|
|
N |
|
CNPI at rest panel; Nonverb pain ind; Pan; Panl; Pnl; Point in time; Random; Resting; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
Organizer |
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
|
|
0 |